In this study, the novel composites were fabricated by the introduction of Mg-0.3Sr-0.3Ca alloy as the matrix and addition of different amounts of graphene nanoplatelets (0.1, 0.2, and 0.4 wt.%) as reinforcement using a stir casting technique followed by homogenization and extrusion in order to improve the mechanical properties of the base alloy. Optimum weight percent of adding graphene nanoplatelets was 0.2 wt.%. The addition of 0.2 wt.% graphene nanoplatelets in the extruded Mg–Sr–Ca alloy led to the grain refinement (∼36%), the decrease of anisotropy (∼14%) and the lowest twin formation. Moreover, the tensile and compressive yield strengths and tensile and compressive fracture strains of extruded Mg-0.3Sr-0.3Ca/0.2GNP composite were enhanced by 22.8%, 66.7%, 43.1% and 28%, respectively. The load transfer was significant strengthening mechanism. The uniform dispersion of graphene nanoplatelets followed by the increase of non-basal slip and grain refinement improved tensile fracture strain. In addition to maintained factors, the increase of compressive fracture strain in the extruded Mg-0.3Sr-0.3Ca/0.2GNP composite was affected by local stresses caused by twins which resulted non-basal slip and conserved basal slip due to presence of twins. Simultaneously, enhancement of the strengthening and elongation efficiencies in both tensile and compressive tests was achieved in Mg-0.3Ca-0.3Sr/0.2GNP. The biocorrosion behavior of extruded Mg-0.3Sr-0.3Ca/0.2GNP composite was promoted by 11% compared with Mg-0.3Sr-0.3Ca alloy. Comparative plots indicated that the fabricated materials can be introduced as a new class of composites for the purpose of structural as well as biomedical applications.
No takes yet. Share an insight, caveat, or question.
Ramezanzade et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: